AU6913100A - Notch receptor ligands and uses thereof - Google Patents

Notch receptor ligands and uses thereof

Info

Publication number
AU6913100A
AU6913100A AU69131/00A AU6913100A AU6913100A AU 6913100 A AU6913100 A AU 6913100A AU 69131/00 A AU69131/00 A AU 69131/00A AU 6913100 A AU6913100 A AU 6913100A AU 6913100 A AU6913100 A AU 6913100A
Authority
AU
Australia
Prior art keywords
receptor ligands
notch receptor
notch
ligands
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69131/00A
Inventor
Michael Rohan
Chan Vivien
Lewis T. Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU6913100A publication Critical patent/AU6913100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU69131/00A 1999-08-19 2000-08-17 Notch receptor ligands and uses thereof Abandoned AU6913100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14993499P 1999-08-19 1999-08-19
US60149934 1999-08-19
PCT/US2000/022609 WO2001012664A2 (en) 1999-08-19 2000-08-17 Notch receptor ligands and uses thereof

Publications (1)

Publication Number Publication Date
AU6913100A true AU6913100A (en) 2001-03-13

Family

ID=22532424

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69131/00A Abandoned AU6913100A (en) 1999-08-19 2000-08-17 Notch receptor ligands and uses thereof

Country Status (4)

Country Link
EP (1) EP1206487A2 (en)
JP (1) JP2003507029A (en)
AU (1) AU6913100A (en)
WO (1) WO2001012664A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1446424A2 (en) * 2001-11-14 2004-08-18 Lorantis Limited Composition comprising inhibitors of the notch signalling pathway for the modulation of the immune system
WO2005014854A1 (en) 2003-08-08 2005-02-17 Licentia, Ltd. Materials and methods for colorectal cancer screening, diagnosis, and therapy
DK3342786T3 (en) 2010-01-29 2021-09-27 Chugai Pharmaceutical Co Ltd Anti-dll3-antistof
CN104520324A (en) 2012-02-24 2015-04-15 施特姆森特Rx股份有限公司 DLL3 modulators and methods of use
HUE043851T2 (en) 2013-02-22 2019-09-30 Abbvie Stemcentrx Llc Antidll3-antibody-pbd conjugates and uses thereof
EP3892294A1 (en) 2013-08-28 2021-10-13 AbbVie Stemcentrx LLC Site-specific antibody conjugation methods and compositions
US10308721B2 (en) 2014-02-21 2019-06-04 Abbvie Stemcentrx Llc Anti-DLL3 antibodies and drug conjugates for use in melanoma
JP7314146B2 (en) 2017-12-28 2023-07-25 中外製薬株式会社 Cytotoxicity-inducing therapeutic agent
KR102505383B1 (en) 2020-03-31 2023-03-02 추가이 세이야쿠 가부시키가이샤 DLL3 Target Multispecific Antigen Binding Molecules and Their Uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786158A (en) * 1992-04-30 1998-07-28 Yale University Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
ATE342358T1 (en) * 1997-04-04 2006-11-15 Millennium Biotherapeutics Inc NEW HUMAN DELTA3 COMPOSITION AND THEIR THERAPEUTIC AND DIAGNOSTIC USES
CA2288218C (en) * 1997-05-14 2013-03-12 Asahi Kasei Kogyo Kabushiki Kaisha Novel differentiation-inhibitor
JP4139508B2 (en) * 1998-02-19 2008-08-27 旭化成株式会社 Human delta 3

Also Published As

Publication number Publication date
WO2001012664A3 (en) 2002-01-10
JP2003507029A (en) 2003-02-25
WO2001012664A2 (en) 2001-02-22
EP1206487A2 (en) 2002-05-22

Similar Documents

Publication Publication Date Title
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU3155501A (en) Spreading factor determination
AU7073800A (en) Novel plexins and uses thereof
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU5319700A (en) Nicotine receptor ligands
AU5967600A (en) Candystraw
AU2841801A (en) Triazolotriazinones and the use thereof
AU7514700A (en) Cyanopiperidines
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU6913100A (en) Notch receptor ligands and uses thereof
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU6440900A (en) Homogentisate-dioxygenase
AU4781100A (en) Ip3 receptor ligands
AU2699800A (en) Organoceramics
AU8919098A (en) Fumonosin resistance
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU3191100A (en) Ligand-bonded complex
AU4561600A (en) Benzofuranylaminoalcohols
AU5979300A (en) Angiopoietin-6 and uses thereof
AU6229999A (en) Garment
AU1901801A (en) Glucofuranoses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase